Medical Radiation Detection, Monitoring & Safety Market Research - Global Forecast to 2029 with Mirion Technologies, Fortive, Thermo Fisher Scientific, and IBA Worldwide Dominating
03 oct. 2024 09h20 HE
|
Research and Markets
Dublin, Oct. 03, 2024 (GLOBE NEWSWIRE) -- The "Medical Radiation Detection, Monitoring & Safety Market by Product (Personal Dosimeters (Passive Dosimeters)), Safety (Full Body, Face Protection,...
Radiotherapy Market Analysis and Forecast 2018-2030: China and India Witnessing Substantial Market Growth Due to Their Large Population Base and Efforts to Improve Cancer Treatment Facilities
03 oct. 2024 04h20 HE
|
Research and Markets
Dublin, Oct. 03, 2024 (GLOBE NEWSWIRE) -- The Radiotherapy Market (By Technology, Procedure, Application, End User, Country Analysis), Company Profiles, Market Dynamics, Trends & Recent...
Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma
16 sept. 2024 09h00 HE
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
Shuttle Pharma Announces Issuance of U.S. Patent for Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease
05 sept. 2024 09h00 HE
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals, a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients...
Shuttle Pharma Provides Second Quarter 2024 Corporate Update
04 sept. 2024 16h15 HE
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
North America Cancer Biopsy Market Research Report 2024
28 août 2024 11h10 HE
|
Research and Markets
Dublin, Aug. 28, 2024 (GLOBE NEWSWIRE) -- The "North America Cancer Biopsy Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
North America $3.62 Bn Nuclear Medicine Market by Country, Competition, Forecast & Opportunities, 2019-2023 & 2024-2029
26 août 2024 10h52 HE
|
Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "North America Nuclear Medicine Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Global Markets Research 2021-2029: Increasing Demand in Developing Regions, Applications Beyond Oncology, Theranostics Gaining Traction
21 août 2024 06h57 HE
|
Research and Markets
Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market...
Shuttle Pharma Ready to Enroll Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
14 août 2024 16h10 HE
|
Shuttle Pharmaceuticals Holdings, Inc.
GAITHERSBURG, Md., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...
Bladder Cancer Therapeutics Market is Likely to Reach USD 456.3 million by 2034 at a CAGR of 4.8% | Report Analysis by Transparency Market Research Inc.
09 août 2024 10h18 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Transparency Market Research, Inc. , Aug. 09, 2024 (GLOBE NEWSWIRE) -- The global bladder cancer therapeutics market(방광암 치료제 시장) stood at US$ 271.4 million in...